Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma
| Image |  |
|---|---|
| Description | scientific article published on 30 July 2019 |
| Author/s |
author: Richard E Kast Mike-Andrew Westhoff Marc-Eric Halatsch Georg Karpel-Massler Annika Dwucet Klaus-Michael Debatin Christian Rainer Wirtz Markus David Siegelin Michal Hlavac |
| Publication date | July 30, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |